Development of a Pharmaceutical Composition and Stablity of Liquid Dosage Forms Based on Monoclonal IgG1 Antibodies
Crossref DOI link: https://doi.org/10.1007/s11094-019-02073-1
Published Online: 2019-12-05
Published Print: 2019-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lomkova, E. A.
Shitikova, V. O.
Tsukur, A. A.
Sozonova, A. A.
Ryakhovskaya, A. M.
Text and Data Mining valid from 2019-11-01
Version of Record valid from 2019-11-01
Article History
Received: 24 September 2018
First Online: 5 December 2019